Deuxième ligne thérapeutique des cancers de vessie avancés: une place réelle pour la vinflunine
N Houédé, G Milano - Bulletin du Cancer, 2019 - Elsevier
Résumé Les carcinomes urothéliaux d'origine vésicale sont des tumeurs particulièrement
agressives avec un fort potentiel métastatique. Leur pronostic a très peu évolué sur les …
agressives avec un fort potentiel métastatique. Leur pronostic a très peu évolué sur les …
Vinflunine in the treatment of advanced bladder cancer
R Mamtani, DJ Vaughn - Expert review of anticancer therapy, 2011 - Taylor & Francis
Accounting for 14,000 deaths in the USA last year, research informs us that advanced
bladder cancer is a lethal disease with a median survival that has remained a little over 1 …
bladder cancer is a lethal disease with a median survival that has remained a little over 1 …
Real-world vinflunine outcomes in bladder cancer in a single-institution study: moving beyond clinical trials
G Moriceau, A Vallard, R Rivoirard, B Méry… - Clinical genitourinary …, 2015 - Elsevier
Purpose Intravenous vinflunine 320 mg/m 2 every 3 weeks plus best supportive care
resulted in better overall survival in comparison with best supportive care alone for eligible …
resulted in better overall survival in comparison with best supportive care alone for eligible …
Monotherapy with intravenous vinflunine in patients with advanced or metastatic urothelial cancer after failure of a platinum-containing regimen: a retrospective …
A Hegele, P Goebell, U Matz, T Neuhaus - Urologia internationalis, 2014 - karger.com
Objective: The objective of this retrospective study was to investigate the efficacy and safety
of vinflunine monotherapy and the utility of second-line prognostic factors in patients with …
of vinflunine monotherapy and the utility of second-line prognostic factors in patients with …
Efficacy and safety of Vinflunine for advanced or metastatic urothelial carcinoma in routine practice based on the French multi-centre CURVE study
J Médioni, M Di Palma, A Guillot, D Spaeth… - BMC cancer, 2016 - Springer
Background To retrospectively assess the efficacy and safety of Vinflunine (VFL) under
routine conditions and identify overall survival (OS) prognostic factors. Methods Twenty …
routine conditions and identify overall survival (OS) prognostic factors. Methods Twenty …
Critical evaluation of vinflunine in the treatment of refractory metastatic urothelial carcinoma
A Morel, D Talbot - Open access journal of urology, 2010 - Taylor & Francis
Urothelial carcinoma (UC) accounts for 5% to 10% of malignancies in men in Europe and
the United States. For locally advanced or metastatic disease, there are two standard firstline …
the United States. For locally advanced or metastatic disease, there are two standard firstline …
Prise en charge du patient métastatique dans le cancer de la vessie
C Théodore - Bulletin du cancer, 2010 - Elsevier
Résumé Le cancer urothélial métastatique ou localement avancé demeure une maladie très
grave. Labase de sa prise en charge repose sur la chimiothérapie systémique. En 30ans …
grave. Labase de sa prise en charge repose sur la chimiothérapie systémique. En 30ans …
Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract: an evidence-based review of safety, efficacy, and place in …
SC Brousell, JJ Fantony, MG Van Noord… - Core …, 2018 - Taylor & Francis
Background: A systematic review and meta-analysis of the use of systemic vinflunine (VIN)
in the treatment of urothelial carcinoma (UC) was performed to evaluate its efficacy based on …
in the treatment of urothelial carcinoma (UC) was performed to evaluate its efficacy based on …
Vinflunine in the treatment of advanced urothelial cancer: clinical evidence and experience
H Gerullis, F Wawroschek… - … advances in urology, 2017 - journals.sagepub.com
Vinflunine (VFL) has been approved in Europe for second-line treatment of metastatic and
advanced urothelial cancer after failure of platin-containing therapy. Since approval, the …
advanced urothelial cancer after failure of platin-containing therapy. Since approval, the …
Vinflunine in routine clinical practice for the treatment of advanced or metastatic urothelial cell carcinoma-data from a prospective, multicenter experience
M Retz, P De Geeter, PJ Goebell, U Matz, W De Schultz… - BMC cancer, 2015 - Springer
Background Vinflunine is recommended in the European guideline for the treatment of
advanced or metastatic urothelial cell carcinoma (UCC) after failure of platinum-based …
advanced or metastatic urothelial cell carcinoma (UCC) after failure of platinum-based …